4.6 Article

Urinary Sodium-to-Potassium Ratio and Blood Pressure in CKD

Journal

KIDNEY INTERNATIONAL REPORTS
Volume 5, Issue 8, Pages 1240-1250

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.ekir.2020.05.025

Keywords

blood pressure; chronic kidney disease; potassium; salt; sodium

Funding

  1. Agence Nationale de la Recherche through the 2010 Cohortes-Investissements d'Avenir program (ANR)
  2. 2010 national Programme Hospitalier de Recherche Clinique
  3. Amgen
  4. Fresenius Medical Care
  5. GlaxoSmithKline (GSK)
  6. Lilly France
  7. Otsuka Pharmaceutical
  8. Baxter
  9. Merck Sharp & Dohme-Chibret (MSD France)
  10. Sanofi-Genzyme
  11. Vifor Fresenius
  12. AstraZeneca

Ask authors/readers for more resources

Introduction: In the general population, urinary sodium-to-potassium (uNa/K) ratio associates more strongly with high blood pressure (BP) than either urinary sodium or potassium alone. Whether this is also the case among patients with chronic kidney disease (CKD) is unknown. Methods: We studied the associations of spot urine sodium-to-creatinine (uNa/Cr), potassium-to-creatinine (uK/Cr), and uNa/K ratios with a single office BP reading in 1660 patients with moderate to severe CKD at inclusion in the CKD-REIN cohort. Results: Patients' median age was 68 (interquartile range [IQR], 59-76) years; most were men (65%), had moderate CKD (57%), and albuminuria (72%). Mean systolic and diastolic BP was 142/78mm Hg. Spot uNa/Cr and uNa/K ratios were positively associated with systolic, mean arterial, and pulse pressures. The mean adjusted difference in systolic BP between the highest and the lowest quartile (Q4 vs. Q1) was 4.24 (95% confidence interval [CI], 1.53-6.96) mm Hg for uNa/Cr and 4.79 (95% CI, 2.18-7.39) mm Hg for uNa/K. Quartiles of spot uK/Cr were not associated with any BP index. The higher the quartile of uNa/K, the higher the prevalence ratio of uncontrolled (Q4 vs. Q1, 1.43; 95% CI, 1.19-1.72) or apparently treatment-resistant hypertension (Q4 vs. Q1, 1.35; 95% CI, 1.14-1.60). Findings were consistent in a subset of 803 individuals with 2 BP readings. Conclusion: In patients with CKD, higher urinary sodium excretion is associated with higher BP, but unlike in general population, lower potassium excretion is not. Urinary Na/K does not add significant value in assessing high BP risk, except perhaps for hypertension control assessment.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Cardiac & Cardiovascular Systems

Diabetic cardiomyopathy: the need for adjusting experimental models to meet clinical reality

Frank Lezoualc'h, Lina Badimon, Hana Baker, Monique Bernard, Gabor Czibik, Rudolf A. de Boer, Thomas D'Humieres, Micheline Kergoat, Mark Kowala, Jennifer Rieusset, Gemma Vilahur, Maximin Detrait, Chris Watson, Genevieve A. Derumeaux

Summary: Diabetic cardiomyopathy is a distinct, multifactorial disease that leads to ventricular hypertrophy and abnormal myocardial contractility. Animal models provide opportunities to study its mechanisms, but there are limitations when extrapolating findings to humans.

CARDIOVASCULAR RESEARCH (2023)

Editorial Material Transplantation

What should European nephrology do with the new CKD-EPI equation?

Ron T. Gansevoort, Hans-Joachim Anders, Mario Cozzolino, Danilo Fliser, Denis Fouque, Alberto Ortiz, Maria Jose Soler, Christoph Wanner

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Article Clinical Neurology

Patient-Reported Quality of Life After Intravenous Alteplase for Stroke in the WAKE-UP Trial

Maerit Jensen, Susanne Sehner, Bastian Cheng, Eckhard Schlemm, Fanny Quandt, Ewgenia Barow, Karl Wegscheider, Florent Boutitie, Martin Ebinger, Matthias Endres, Jochen B. Fiebach, Vincent Thijs, Robin Lemmens, Keith W. Muir, Norbert Nighoghossian, Salvador Pedraza, Claus Z. Simonsen, Goetz Thomalla, Christian Gerloff

Summary: The study found that intravenous alteplase may have a potential benefit for health-related quality of life (HRQoL) beyond its effect on functional outcome.

NEUROLOGY (2023)

Review Cell Biology

Pathogenic Role of Adipose Tissue-Derived Mesenchymal Stem Cells in Obesity and Obesity-Related Inflammatory Diseases

Julien Pestel, Ferdinand Blangero, Assia Eljaafari

Summary: Adipose tissue-derived mesenchymal stem cells (ASCs) exhibit both pro-inflammatory and anti-inflammatory properties depending on the microenvironmental stimuli. In pathological contexts like obesity, ASCs can contribute to the development of obesity-related inflammatory diseases. This review aims to highlight the pathogenic role of ASCs in obesity and describe the mechanisms leading to their dysfunctions, involving factors such as adhesion molecules, TLRs, Th17 cells, Th22 cells, gamma delta T cells, and immune checkpoint overexpression.

CELLS (2023)

Letter Endocrinology & Metabolism

Dulaglutide and insulin microsecretion in people with type 1 diabetes (DIAMOND-GLP-1): A randomized double-blind placebo-controlled trial

Charles Thivolet, Etienne Larger, Bertrand Cariou, Eric Renard, Helene Hanaire, Pierre -Yves Benhamou, Bruno Guerci, Emilie Mathiotte, Karim Chikh

DIABETES & METABOLISM (2023)

Review Geriatrics & Gerontology

Impact of Age on Poly(ADP-Ribose) Polymerase Inhibitor (PARPi)-Induced Lymphopenia: A Scoping Review of the Literature and Internal Analysis of a Retrospective Database

Gabriel Antherieu, Mael Heiblig, Gilles Freyer, Herve Ghesquieres, Claire Falandry

Summary: This study found a high incidence of lymphopenia in adult patients treated with PARPi, especially in older patients, through a retrospective cohort study and scoping review analysis. Future work is needed to improve patient follow-up and discuss prophylactic strategies.

DRUGS & AGING (2023)

Review Nutrition & Dietetics

Caring for Patients With Advanced Chronic Kidney Disease: Dietary Options and Conservative Care Instead of Maintenance Dialysis

Kamyar Kalantar-Zadeh, Vincenzo Bellizzi, Giorgina B. Piccoli, Yunying Shi, Soo Kun Lim, Sumira Riaz, Rocio Urbina Arronte, Wai Pooi Lau, Denis Fouque

Summary: An expert advisory board discussed the prevention and treatment of CKD, with a focus on dietary options. The timing of dialysis start is influenced by patients' clinical status and patient-clinician interactions. Therapies that preserve kidney function, such as adjusting lifestyle and diet, can prolong the dialysis-free period and improve CKD management.

JOURNAL OF RENAL NUTRITION (2023)

Article Clinical Neurology

Blood-Brain Barrier Permeability and Kinetics of Inflammatory Markers in Acute Stroke Patients Treated With Thrombectomy

Alexandre Bani-Sadr, Laura Mechtouff, Charles De Bourguignon, Aela Mauffrey, Timothe Boutelier, Tae-Hee Cho, Matteo Cappucci, Roxana Ameli, Marc Hermier, Laurent Derex, Norbert Nighoghossian, Yves Berthezene

Summary: This study aimed to investigate the relationship between baseline blood-brain barrier (BBB) permeability and the kinetics of circulating inflammatory markers in acute ischemic stroke (AIS) patients treated with mechanical thrombectomy. It was found that increased BBB permeability was associated with a larger ischemic core and higher levels of inflammatory markers. In patients with symptom onset <6 hours, increased BBB permeability was also associated with higher MMP-9 levels.

NEUROLOGY (2023)

Article Clinical Neurology

Intravenous Thrombolysis in Patients With White Matter Hyperintensities in the WAKE-UP Trial

Benedikt Frey, Farhad Shenas, Florent Boutitie, Bastian Cheng, Tae-Hee Cho, Martin Ebinger, Matthias B. Endres, Jochen Fiebach, Jens Fiehler, Ivana Galinovic, Ewgenia Barow, Alina Koenigsberg, Eckhard Schlemm, Salvador Pedraza, Robin Lemmens, Vincent W. Thijs, Keith Muir, Norbert Z. Nighoghossian, Claus Simonsen, Christian Gerloff, Goetz Thomalla, WAKE-UP Investigators

Summary: This study aimed to evaluate the impact of white matter hyperintensities burden on the efficacy and safety of thrombolysis in stroke patients with unknown onset. The results showed that WMH burden was associated with worse functional outcome, but did not increase the risk of hemorrhagic transformation. In patients with severe WMH, intravenous thrombolysis was associated with a higher likelihood of excellent outcome without a significant increase in the rate of hemorrhagic transformation.

STROKE (2023)

Correction Geriatrics & Gerontology

Correction: Procalcitonin to reduce exposure to antibiotics and individualise treatment in hospitalised old patients with pneumonia: a randomised study (vol 22, 965, 2022)

Gaetan Gavazzi, Sabine Drevet, Matthieu Debray, Jean Luc Bosson, Fatah Tidadini, Marc Paccalin, Benoit de Wazieres, Thomas Celarier, Marc Bonnefoy, Virginie Vitrat

BMC GERIATRICS (2023)

Review Oncology

How Warburg-Associated Lactic Acidosis Rewires Cancer Cell Energy Metabolism to Resist Glucose Deprivation

Zoe Daverio, Aneta Balcerczyk, Gilles J. P. Rautureau, Baptiste Panthu

Summary: Lactic acidosis is a crucial factor in the tumor microenvironment and cancer metabolism. This review aims to explore the mechanisms through which lactic acidosis affects cancer cell metabolism and its contribution to the understanding of tumor metabolism. It also highlights the therapeutic potentials of lactic acidosis.

CANCERS (2023)

Article Cardiac & Cardiovascular Systems

Challenges and Opportunities in Titrating Disease-Modifying Therapies in Heart Failure with Reduced Ejection Fraction and Chronic Kidney Disease

Stefana Enachi, Maxime Schleef, Chahr-Eddine Hadjseyd, Simon Leboube, Charles Fauvel, Lucie Daniel, Antoine Jobbe-Duval, Laurent Sebbag, Sandrine Lemoine, Nathan Mewton

Summary: Chronic kidney disease (CKD) is common in patients with heart failure and reduced ejection fraction (HFrEF), and it is a major factor contributing to adverse outcomes. Despite limited data, studies have shown that HFrEF therapies continue to be effective in improving cardiovascular outcomes in patients with CKD. Most HF drugs cause acute renal hemodynamic changes, but these changes stabilize or even improve after the acute phase, without long-term deterioration of renal function. This paper challenges the misconceptions about the pathophysiology of HF that hinder the implementation of disease-modifying therapy in this context and proposes a strategy for titrating HF drugs in patients with moderate, severe, and end-stage CKD.

CURRENT HEART FAILURE REPORTS (2023)

Article Biochemistry & Molecular Biology

Adipose tissue angiogenesis genes are down-regulated by grape polyphenols supplementation during a human overfeeding trial

Pauline Delage, Berenice Segrestin, Kevin Seyssel, Stephanie Chanon, Aurelie Vieille-Marchiset, Annie Durand, Angeline Nemeth, Sylviane Metairon, Aline Charpagne, Patrick Descombes, Jorg Hager, Martine Laville, Hubert Vidal, Emmanuelle Meugnier

Summary: The adaptive response to overfeeding involves significant changes in gene expression in adipose tissue. This study investigated whether supplementation with polyphenols could affect these molecular adaptations in lean men. The results showed that polyphenol supplementation modulated gene expression in adipose tissue and potentially protected against adipose tissue expansion during weight gain.

JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Brush sign and collateral supply as potential markers of large infarct growth after successful thrombectomy

Alexandre Bani-Sadr, Dylan Pavie, Laura Mechtouff, Matteo Cappucci, Marc Hermier, Roxana Ameli, Laurent Derex, Charles De Bourguignon, Tae-Hee Cho, Omer Eker, Norbert Nighoghossian, Yves Berthezene

Summary: The presence of brush sign is associated with infarct growth after successful thrombectomy, while cerebral collateral status is not.

EUROPEAN RADIOLOGY (2023)

Article Critical Care Medicine

Valproic acid as adjuvant treatment for convulsive status epilepticus: a randomised clinical trial

Tarek Sharshar, Raphael Porcher, Pierre Asfar, Lamiae Grimaldi, Julien Jabot, Laurent Argaud, Christine Lebert, Pierre-Edouard Bollaert, Marie Line Harlay, Patrick Chillet, Eric Maury, Francois Santoli, Pascal Blanc, Romain Sonneville, Vu Dinh Chuyen, Benjamin Rohaut, Aurelien Mazeraud, Jean-Claude Alvarez, Vincent Navarro, Bernard Clair, Herve Outin

Summary: This multicentre, double-blind, randomised controlled trial in 244 adults with GCSE found that adding VPA as a complementary treatment to the recommended strategy did not increase the proportion of patients discharged from hospital by day 15.

CRITICAL CARE (2023)

No Data Available